AKT1 and diffuse large B-cell lymphoma: Taken together, these data indicate that DENND1A as RAB35 guanine nucleotide exchange factor, may participate in regulating the PI3K/AKT signaling pathway affecting DLBCL progress, but its specific mechanism is unclear.